AtriCure wins 510(k) clearance for anti-clot device

June 15, 2010 by MedCity News

AtriCure Inc. wins 510(k) clearance from the Food & Drug Administration for its AtriClip anti-clot device.

MedCity News logo

AtriCure Inc. (NSDQ:ATRC) won 510(k) clearance from the Food & Drug Administration for its AtriClip device, which protects against blood clots during heart procedures.

The news sent AtriCure’s stock soaring 17 percent, to $6.13, in early after-hours trading June 14.

The West Chester, Ohio-based company plans an initial launch of the device later this month, with a full commercial release coming in the third quarter, according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp